Wall Street Experts
ver. ZuMIgo(08/25)
Shenzhen YHLO Biotech Co., Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 1 892
EBIT TTM (mln): 302
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
530 |
729 |
877 |
999 |
1,178 |
3,981 |
2,043 |
2,012 |
Przychód Δ r/r |
0.0% |
37.5% |
20.4% |
13.9% |
17.9% |
238.0% |
-48.7% |
-1.5% |
Marża brutto |
36.6% |
39.6% |
50.7% |
60.2% |
56.8% |
54.0% |
100.0% |
65.3% |
EBIT (mln) |
14 |
50 |
126 |
247 |
227 |
1,202 |
336 |
315 |
EBIT Δ r/r |
0.0% |
267.8% |
151.4% |
95.7% |
-8.0% |
429.8% |
-72.0% |
-6.4% |
EBIT (%) |
2.6% |
6.9% |
14.4% |
24.7% |
19.3% |
30.2% |
16.5% |
15.7% |
Koszty finansowe (mln) |
2 |
5 |
18 |
13 |
11 |
8 |
0 |
12 |
EBITDA (mln) |
25 |
89 |
204 |
339 |
357 |
1,426 |
365 |
571 |
EBITDA(%) |
4.6% |
12.2% |
23.3% |
33.9% |
30.3% |
35.8% |
17.9% |
28.4% |
Podatek (mln) |
8 |
12 |
20 |
34 |
24 |
165 |
-28 |
40 |
Zysk Netto (mln) |
6 |
38 |
108 |
211 |
205 |
1,012 |
358 |
302 |
Zysk netto Δ r/r |
0.0% |
545.2% |
182.8% |
95.8% |
-2.7% |
394.5% |
-64.6% |
-15.9% |
Zysk netto (%) |
1.1% |
5.2% |
12.3% |
21.1% |
17.4% |
25.4% |
17.5% |
15.0% |
EPS |
0.0143 |
0.0786 |
0.19 |
0.37 |
0.36 |
1.79 |
0.63 |
0.53 |
EPS (rozwodnione) |
0.0143 |
0.0786 |
0.19 |
0.37 |
0.36 |
1.78 |
0.63 |
0.53 |
Ilośc akcji (mln) |
413 |
484 |
567 |
567 |
567 |
566 |
569 |
569 |
Ważona ilośc akcji (mln) |
413 |
484 |
567 |
567 |
567 |
569 |
569 |
569 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |